View Author
patient trial infarction study stroke treatment mortality stent death event group outcome /iiia heart therapy artery table elevation 30 days investigator platelet intervention circulation baseline result ck-mb syndrome analysis eptifibatide model ratio glycoprotein effect pursuit heparin angina nonhemorrhagic stroke percutaneou level disease placebo difference troponin nonhemorrhagic revascularization coll cardiol randomized predictor cardiol 30- day mortality abciximab factor thrombolytic 30- hospital characteristic creatine value receptor diabetes aspirin st-segment angioplasty swets subs service reduction follow-up variable thrombolytic therapy survival inhibitor month surgery strategy st-segment elevation thrombocytopenia history figure hemorrhage heart failure eur heart j
10 Most Recent Publications
|
Common variants in KCNN3 are associated with lone atrial fibrillation
(Article)
Ellinor, P.T. Lunetta, K.L. Fox, E.R. Darbar, D. Smith, N.L. Schnabel, R. Soliman, E.Z. Rice, K. Wagoner, D.R. van Beckmann, B.M. Noord, C. van Wang, T.J. Glazer, N.L. Ehret, G.B. Rotter, J.I. Hazen, S.L. Steinbeck, G. Launer, L.J. Harris, T.B. Makino, S. Nelis, M. Milan, D.J. Perz, S. Pfeufer, A. Esko, T. Köttgen, A. Moebus, S. Newton-Cheh, C. Li, M. Möhlenkamp, S. Linda Kao, W.H. Vasan, R.S. Nöthen, M.M. MacRae, C.A. Alonso, A. Stricker, B.H.Ch. Hofman, A. Uitterlinden, A.G. Levy, D. Boerwinkle, E. Metspalu, A. Topol, E.J. Chakravarti, A. Gudnason, V. Psaty, B.M. Chung, M.K. Roden, D.M. Meitinger, T. Wichmann, H.E. Witteman, J.C.M. Barnard, J. Arking, D.E. Benjamin, E.J. Heckbert, S.R. Kääb, S. Sinner, M.F. Bakker, P.I.W. de Mueller, M. Lubitz, S.A. |
2010-03-01
|
|
Relation Between Aspirin Dose, All-Cause Mortality, and Bleeding in Patients With Recent Cerebrovascular or Coronary Ischemic Events (from the BRAVO Trial)
(Article)
Aronow, H.D. Califf, R.M. Ferguson, J.J. Koudstaal, P.J. Amarenco, P. Theroux, P. Davis, S.M. Topol, E.J. Harrington, R.A. Vallee, M. Graffagnino, C. Shuaib, A. Fitzgerald, D. Easton, J.D. Werf, F.J.J. van de Diener, H.C. |
2008-11-15
|
|
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: Results from four large clinical trials
(Article)
Mahaffey, K.W. Roe, M.T. Kilaru, R. Alexander, J.H. Werf, F.J.J. van de Califf, R.M. Simoons, M.L. Topol, E.J. Harrington, R.A. |
2007-02-01
|
|
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
(Article)
Labinaz, M. Mathias, J. Califf, R.M. Topol, E.J. Harrington, R.A. Armstrong, P.W. Pieper, K.S. Granger, C.B. Lincoff, A.M. Moliterno, D.J. Werf, F.J.J. van de Simes, R.J. White, H.D. Simoons, M.L. |
2005-01-01
|
|
Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
(Article)
Roe, M.T. Mahaffey, K.W. Lincoff, A.M. Califf, R.M. Topol, E.J. Werf, F.J.J. van de Alexander, J.H. Armstrong, P.W. Kilaru, R. Akkerhuis, K.M. Simoons, M.L. Harrington, R.A. Tardiff, B.E. Granger, C.B. Ohman, E.M. Moliterno, D.J. |
2004-02-01
|
|
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
(Article)
James, S.K. Lindahl, B. Armstrong, P.W. Siegbahn, A. Stridsberg, M. Venge, P. Barnathan, E.S. Califf, R.M. Topol, E.J. Simoons, M.L. Wallentin, L.C. |
2003-07-22
|
|
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease
(Article)
Topol, E.J. Easton, D. Granett, J.R. Shuaib, A. Koudstaal, P.J. Theroux, P. Werf, F.J.J. van de Sigmon, K.N. Pieper, K.S. Vallee, M. Willerson, J.T. Harrington, R.A. Amarenco, P. Califf, R.M. Graffagnino, C. Davis, S.M. Diener, H.C. Ferguson, J.J. Fitzgerald, D. |
2003-07-01
|
|
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome. A GUSTO IV substudy
(Article)
James, S.K. Barnathan, E.S. Califf, R.M. Lindahl, B. Siegbahn, A. Simoons, M.L. Topol, E.J. Venge, P. Wallentin, L.C. Armstrong, P.W. |
2003-03-19
|
|
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina
(Article)
Ottervanger, J.P. Barnathan, E.S. Cooper, J.S. Ohman, E.M. James, S.K. Topol, E.J. Wallentin, L.C. Simoons, M.L. Boersma, H. Armstrong, P.W. |
2003-01-28
|
|
Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (Platelet Glycoprotein IIb/IIIa in unstable angina: receptor suppression using integreling therapy)
(Article)
Breeman, A. Mercado, N.F. Lenzen, M.J. Harrington, R.A. Califf, R.M. Topol, E.J. Simoons, M.L. Brand, M.J.B.M. van den Boersma, H. |
2002-12-01
|
